TPPII-related immunodeficiency is a rare, inherited immune system disorder caused by harmful changes (pathogenic variants) in a gene called TPP2, which makes an enzyme named tripeptidyl-peptidase II (TPPII). When TPPII does not work properly, immune cells cannot keep their internal protein recycling and energy balance steady. As a result, both immune defense (fighting infections) and immune control (preventing the immune system from attacking the body itself) are disturbed. People with this condition often get recurrent infections, develop autoimmune problems (especially Evans syndrome, which means autoimmune anemia plus autoimmune low platelets), and may show neurodevelopmental or learning difficulties. Doctors usually confirm the diagnosis by finding biallelic (both-copy) TPP2 variants and by seeing a matching pattern of immune test results and symptoms. orpha.net+2PMC+2

TPPII-related immunodeficiency is a very rare, inherited immune disorder caused by harmful (“biallelic”) changes in the TPP2 gene, which encodes the large protease tripeptidyl-peptidase II (TPPII). People with this condition often have repeated infections, signs of immune over-activity (autoimmunity—classically Evans syndrome, where the immune system destroys red cells and platelets), and developmental or neurologic concerns; the disease mechanism links disturbed protein breakdown with T- and B-cell premature aging, impaired glycolysis, and enlarged lysosomes. It is inherited in an autosomal recessive pattern. UniProt+3ScienceDirect+3PMC+3

In simple terms: TPPII is part of the cell’s “cleanup and trimming” machinery and also helps shape immune metabolism. When TPPII is missing or broken, immune cells tire early (“senescence”), process antigens abnormally, and cannot make energy efficiently—so infections occur more often and the immune system may also attack the body itself. ScienceDirect+2PMC+2

Other names

Doctors and databases may use different names for the same disorder. You might see:

• TRIANGLE disease (short for “TPPII-related immunodeficiency, autoimmunity, and neurodevelopmental delay with impaired glycolysis and lysosomal expansion”). This name points to the three major features: immunodeficiency, autoimmunity, and neurodevelopmental issues, plus the key cell changes (low glycolysis and enlarged lysosomes). orpha.net+1

• Autoimmune hemolytic anemia–autoimmune thrombocytopenia–primary immunodeficiency due to TPP2 deficiency (the Orphanet label). orpha.net+1

• TPP2 deficiency, TPPII deficiency, or tripeptidyl-peptidase II deficiency (short forms used in papers). PMC+1

Types

Because this is a very rare condition, doctors describe “types” by clinical patterns rather than official sub-types:

1. Classic TRIANGLE pattern: recurrent infections + autoimmune cytopenias (often Evans syndrome) + developmental delay. PMC+1

2. Immune-dominant pattern: mostly infections and autoimmunity, with little or no neurological involvement. SpringerLink

3. Neuro-inflammatory pattern: sterile brain inflammation mimicking multiple sclerosis (MS-like episodes), sometimes with milder immune symptoms. American Academy of Neurology

4. Variable-expressivity pattern: same gene change in a family but different severity from one person to another. This has been reported in small series. Wiley Online Library+1

Causes

Think of one root cause and many drivers/modifiers that shape how the disease looks in each person.

1. Biallelic pathogenic TPP2 variants (the fundamental cause): when both copies of TPP2 are damaged, TPPII enzyme activity drops and immune cells can’t keep protein breakdown and energy balance steady. PMC+1

2. Loss of amino-acid homeostasis: low TPPII makes cells short on free amino acids, forcing them to overuse their lysosomes (cell “stomachs”). PMC

3. Lysosomal expansion: too many overactive lysosomes appear and start digesting important proteins the cell still needs. PMC

4. Hexokinase-2 (HK2) degradation: lysosomes remove HK2, a key “on-switch” for glycolysis (sugar-to-energy pathway). Energy falls and immune cells tire easily. PMC+1

5. Reduced glycolysis in immune cells: T cells, NK cells, and innate cells cannot make energy fast enough to respond strongly. ScienceDirect

6. Low cytokine output: cells release less IFN-γ, IL-2, and IL-1β, weakening coordination of immune responses. ScienceDirect

7. Premature immunosenescence: T and B cells act “old” too early (shortened replicative capacity, altered markers), decreasing their effectiveness. PMC+1

8. Faulty antigen processing: TPPII helps trim peptides for HLA class I presentation; its loss can disturb how immune cells “show” antigens, confusing surveillance. Wikipedia

9. Autoimmunity trigger: when immune control is unstable, self-reactive cells may survive and attack red cells and platelets (Evans syndrome). PMC

10. Lymphoproliferation: immune activation without proper brakes can enlarge lymph nodes, liver, and spleen. UniProt

11. Founder or family variants: certain populations may share a founder variant, affecting risk in relatives. PubMed

12. Intercurrent viral infections: common viruses can expose the weakness of the immune system, causing frequent or severe infections. PMC

13. Vaccination antibody failure (in some patients): poor antibody responses after routine vaccines reveal B-cell dysfunction. SpringerLink

14. NK-cell dysfunction: reduced cytotoxicity lowers early antiviral defense. ScienceDirect

15. Regulatory T-cell imbalance: when T-reg brakes are weak, autoimmunity risks rise. (Reported within the broader immune-dysregulation picture in series.) PMC

16. Metabolic stress: chronic low energy in immune cells magnifies both infection risk and autoimmune mis-firing. ScienceDirect

17. Gene–environment mix: nutrition, intercurrent illness, and microbiome differences may shape severity in rare monogenic immune disorders. (General principle in primary immunodeficiencies.) jacionline.org

18. Age-related demands: infancy/early childhood bring high pathogen exposure; deficits show up early. PMC

19. Heterogeneity of variants: missense, nonsense, or splice changes can produce milder or more severe enzyme loss and different clinical pictures. Wiley Online Library

20. Chance (stochastic): with very few patients globally, random factors also influence how the disease unfolds in each person. (Observed variability in case series.) Wiley Online Library

Common symptoms and signs

1. Frequent infections: repeated ear, sinus, chest, or skin infections due to poor immune energy and signaling. PMC

2. Severe or unusual infections: common germs may cause unusually hard-to-treat illness; sometimes opportunistic infections appear. UniProt

3. Autoimmune hemolytic anemia: the immune system destroys red blood cells, causing pallor, tiredness, and jaundice. PMC

4. Autoimmune thrombocytopenia: the immune system attacks platelets, leading to easy bruising or nosebleeds. Together with anemia this is Evans syndrome. PMC

5. Neurodevelopmental delay or learning problems: some patients have speech, motor, or cognitive delays. Wiley Online Library

6. MS-like brain inflammation: a few patients have sterile inflammatory brain episodes that mimic multiple sclerosis. American Academy of Neurology

7. Enlarged spleen and liver: because immune cells are over-active and blood cells are destroyed, the spleen/liver may grow. UniProt

8. Enlarged lymph nodes: persistent immune activation can swell nodes in the neck, armpits, or groin. UniProt

9. Poor weight gain or growth: chronic illness and high energy demands can slow growth. UniProt

10. Fatigue: low red cell counts and low immune-cell energy can both make people very tired. ScienceDirect

11. Fevers: repeated or prolonged fevers from infections or inflammatory flares. UniProt

12. Mouth ulcers or mucosal problems: sometimes linked to immune dysregulation. UniProt

13. Skin rashes: from infections, autoimmunity, or inflammation. UniProt

14. Respiratory issues: recurrent cough or pneumonia due to weak defense. UniProt

15. Bleeding symptoms: petechiae (tiny red spots), gum bleeding, or heavy periods related to low platelets. PMC

Diagnostic tests

A) Physical examination

1. Growth and nutrition check: height/weight tracking shows if long-standing illness has slowed growth. This is standard in primary immunodeficiency care. UniProt

2. Lymph node, liver, and spleen exam: feeling for enlargement helps track lymphoproliferation and hemolysis-related spleen growth. UniProt

3. Skin and mucosa exam: rashes, mouth ulcers, or infection signs point to immune problems. UniProt

4. Bleeding assessment: bruises or petechiae suggest immune thrombocytopenia (part of Evans syndrome). PMC

5. Neurologic screening: tone, reflexes, gait, and vision checks look for neurodevelopmental or MS-like changes. American Academy of Neurology

B) “Manual” or bedside tests

6. Temperature and infection focus checks: repeated fever patterns point to susceptibility. UniProt

7. Functional bedside neuro testing: simple balance, coordination, and vision tasks can hint at brain inflammation if symptoms change over time. American Academy of Neurology

8. Bleeding time proxies (clinical): careful observation of nosebleeds or gum bleeding patterns helps triage platelet problems before labs confirm. PMC

C) Laboratory and pathology tests

9. Complete blood count (CBC) with smear: looks for anemia, thrombocytopenia, or abnormal white cells; smear may show hemolysis signs. PMC

10. Reticulocyte count, LDH, bilirubin, haptoglobin: hemolysis panel confirms autoimmune red-cell destruction. PMC

11. Direct antiglobulin test (Coombs test): detects antibodies on red cells—key for autoimmune hemolytic anemia. PMC

12. Immunoglobulin levels (IgG, IgA, IgM): may be low, normal, or skewed; helps map B-cell function. SpringerLink

13. Specific antibody titers after vaccines: checks whether the body makes protective antibodies. SpringerLink

14. Flow cytometry lymphocyte subsets: counts of T, B, and NK cells; some patients show altered numbers or memory phenotypes (“immunosenescence”). PMC+1

15. T-cell proliferation tests: measure how T cells respond to stimuli; may be reduced. SpringerLink

16. Cytokine production assays: IFN-γ, IL-2, and IL-1β output can be low, reflecting the metabolic block. ScienceDirect

17. Natural killer (NK) cytotoxicity: may be impaired, explaining viral susceptibility. ScienceDirect

18. Genetic testing for TPP2: confirms biallelic pathogenic variants; often by exome, gene panels, or targeted sequencing. Wiley Online Library+1

D) Electrodiagnostic tests

19. EEG (if seizures or acute encephalopathy): looks for abnormal brain electrical activity during neuro-inflammatory episodes. (Used in reported neuroinflammatory cases for evaluation.) American Academy of Neurology

20. Evoked potentials (as clinically indicated): may help assess optic or spinal pathways in MS-like presentations. (Part of standard MS-mimic work-ups reported in case literature.) American Academy of Neurology

E) Imaging tests

21. Brain MRI: checks for demyelinating-type lesions or sterile inflammation in MS-like presentations. American Academy of Neurology

22. Chest imaging (X-ray or CT): evaluates recurrent pneumonia or unusual infections. UniProt

23. Abdominal ultrasound: measures spleen and liver size to track hemolysis or lymphoproliferation. UniProt

24. Sinus CT (if needed): recurrent sinus infections may warrant detailed imaging. UniProt

25. PET-CT (selected cases): helps when doctors need to distinguish hyperactive immune tissue from infection or other causes. (General immune-dysregulation use in reports.) UniProt

Non-pharmacological treatments (therapies & other supports)

Each item includes what it is, purpose, and mechanism in simple words.

1. Infection-prevention bundle at home — rigorous hand hygiene, cough etiquette, safe food/water, and avoiding sick contacts reduce pathogen exposure; fewer germs means fewer infections for a stressed immune system. Frontiers

2. Up-to-date household vaccinations — even if the patient’s own vaccine response is weak, immunizing family/caregivers creates a protective “cocoon,” lowering pathogen circulation around the patient. Frontiers

3. Masking during outbreaks — a physical barrier lowers inhaled viral dose; this can cut severity and frequency of respiratory infections when immunity is compromised. Frontiers

4. Nutrition therapy (dietitian-led) — ensuring adequate calories, protein, and key micronutrients (vitamin D, C, zinc, selenium) supports barrier integrity and immune cell function; even marginal deficiencies can blunt immunity. PMC+1

5. Oral care & dental hygiene — daily brushing/flossing and regular dental checks reduce oral bacterial load and prevent bloodstream seeding from gingival inflammation. Frontiers

6. Skin care & wound hygiene — gentle cleansers, moisturizers, and prompt cleansing/covering of cuts keep the skin barrier intact, lowering bacterial entry. Frontiers

7. Respiratory physiotherapy (as needed) — airway clearance (huff cough, PEP devices) helps mobilize mucus, improving ventilation and reducing bacterial overgrowth after infections. Frontiers

8. Sleep optimization — regular, sufficient sleep supports immune signaling and antibody responses; poor sleep raises infection risk. PMC

9. Stress-reduction (mind-body skills) — paced breathing, brief mindfulness, or CBT reduce stress hormones that can suppress aspects of immunity, aiding balance. PMC

10. Physical activity as tolerated — gentle, regular movement improves circulation, mood, and immune surveillance without exhausting the patient. PMC

11. Sunlight & safe vitamin D plan — coordinated with labs and clinician oversight; vitamin D affects innate defenses and antimicrobial peptides. PMC+1

12. Developmental/rehabilitation therapies — early speech/occupational/physical therapy supports neurodevelopment and function when delays are present. orpha.net

13. Education planning & school health plans — individualized education programs and infection-control accommodations lower absences and risk. orpha.net

14. Allergy/environment controls — reduce mold, dust, and irritants that inflame airways and predispose to infections. Frontiers

15. Safe food practices — avoid raw/undercooked animal products; wash produce; separate cutting boards to prevent food-borne illness. Frontiers

16. Probiotic foods—with caution — fermented foods may support gut barrier in the generally well, but supplements can rarely cause infection in the immunocompromised; use only with clinician approval. PMC+1

17. Sun/skin protection — reduces secondary skin damage/infection from burns or dermatitis. Frontiers

18. Home care protocols & emergency plans — teach families red-flag symptoms and have a low threshold for early evaluation to prevent escalation. Frontiers

19. Genetic counseling — explains autosomal-recessive inheritance, carrier testing, and family planning choices. NCBI

20. Telemedicine check-ins — frequent, short follow-ups allow proactive adjustments to prevent infections or autoimmune flares. Frontiers

---

Drug treatments

Because there are no TPPII-specific approved drugs, clinicians combine infection prevention/replacement with autoimmunity control, tailoring doses to the person. Dosages below are common reference ranges for adults unless noted; your clinician will individualize.

1. IVIG (intravenous immunoglobulin) — Class: immune replacement. Dose/time: 0.4–1 g/kg every 3–4 weeks (or SCIG weekly). Purpose: reduce infections; sometimes tempers autoimmunity. Mechanism: provides pooled antibodies; Fc-mediated immune modulation. Side effects: headache, aseptic meningitis, thrombosis (rare), infusion reactions. Frontiers

2. Prophylactic antibiotics (e.g., trimethoprim-sulfamethoxazole) — Class: antimicrobial. Dose: low daily/3×weekly regimens vary. Purpose: prevent recurrent bacterial/some opportunistic infections. Mechanism: folate pathway inhibition. Side effects: rash, cytopenias, hyperkalemia; watch for sulfa allergy. Frontiers

3. Antiviral prophylaxis (acyclovir/valacyclovir when indicated) — Class: antiviral. Purpose: prevent severe HSV/VZV reactivation in susceptible patients. Mechanism: viral DNA polymerase inhibition. Side effects: GI upset, renal dosing issues. Frontiers

4. Antifungal prophylaxis (fluconazole or others per risk) — Class: antifungal. Purpose: reduce candidal infections if recurrent. Mechanism: ergosterol synthesis inhibition. Side effects: liver enzymes, drug interactions. Frontiers

5. Corticosteroids (prednisone) — Class: immunosuppressant. Dose: often 0.5–1 mg/kg/day short course for Evans syndrome flares. Purpose: quickly reduce hemolysis/thrombocytopenia. Mechanism: broad cytokine suppression. Side effects: weight gain, hyperglycemia, infection risk, bone loss. PMC+1

6. Rituximab — Class: anti-CD20 monoclonal antibody. Dose: 375 mg/m² weekly × 4 (typical). Purpose: steroid-sparing control of autoimmune cytopenias. Mechanism: depletes B cells that make pathogenic antibodies. Side effects: infusion reactions, prolonged hypogammaglobulinemia, infection risk. haematologica.org+2PMC+2

7. Mycophenolate mofetil — Class: antimetabolite immunosuppressant. Dose: 500–1,000 mg twice daily. Purpose: maintain remission in autoimmune cytopenias. Mechanism: inhibits inosine monophosphate dehydrogenase, reducing lymphocyte proliferation. Side effects: GI upset, leukopenia, teratogenicity. PMC

8. Azathioprine — Class: antimetabolite. Dose: ~1–2 mg/kg/day. Purpose: steroid-sparing for chronic autoimmunity. Mechanism: purine analog suppressing lymphocyte proliferation. Side effects: myelosuppression (check TPMT), liver toxicity, infection. PMC

9. Cyclosporine — Class: calcineurin inhibitor. Dose: individualized by trough. Purpose: refractory Evans syndrome. Mechanism: blocks T-cell IL-2 transcription. Side effects: nephrotoxicity, hypertension, tremor. PMC

10. Sirolimus (rapamycin) — Class: mTOR inhibitor. Dose: guided by levels. Purpose: immune dysregulation control (some PIDs respond). Mechanism: mTOR blockade modulates T-cell metabolism and proliferation. Side effects: mouth ulcers, hyperlipidemia, cytopenias. PMC+1

11. Tacrolimus — Class: calcineurin inhibitor. Purpose: alternative steroid-sparing agent. Mechanism: inhibits T-cell activation. Side effects: nephrotoxicity, neurotoxicity, infections. jaci-inpractice.org

12. Thrombopoietin receptor agonists (eltrombopag/romiplostim) — Class: platelet growth stimulants. Purpose: raise platelets in refractory immune thrombocytopenia within Evans. Mechanism: drives megakaryocyte/platelet production. Side effects: thrombosis risk, liver enzymes. PMC

13. G-CSF (filgrastim) — Class: hematopoietic growth factor. Purpose: support neutrophil counts during infections or drug-induced neutropenia. Mechanism: stimulates marrow granulopoiesis. Side effects: bone pain, leukocytosis, rare splenic effects. Frontiers

14. Hydroxychloroquine — Class: immunomodulator. Purpose: adjunct in autoimmune cytopenias or SLE overlap. Mechanism: interferes with antigen presentation and endosomal TLR signaling. Side effects: retinal toxicity (rare), GI. PMC

15. Rituximab + IVIG (combination in refractory autoimmunity) — Rationale: sequential/combined therapy can improve control in some autoimmune settings; used case-by-case in PID. Risks: deeper hypogammaglobulinemia—monitor carefully. BioMed Central

16. Broad-spectrum empiric antibiotics (for febrile episodes) — Purpose: early, aggressive treatment of suspected serious infection. Mechanism: covers likely pathogens while cultures are pending. Side effects: C. difficile risk, resistance; use stewardship. Frontiers

17. Antiviral therapy for active infections (e.g., oseltamivir, acyclovir, ganciclovir per virus) — Purpose: shorten and control severe viral disease. Mechanism/AE: virus-specific; dosing and renal/hematologic monitoring required. Frontiers

18. Antifungals for invasive disease (e.g., echinocandins, voriconazole) — Purpose: treat proven/suspected fungal infections. Mechanism/AE: cell-wall or ergosterol pathway inhibition; monitor liver/QT. Frontiers

19. Pneumocystis prophylaxis (TMP-SMX or alternatives) — Purpose: prevent Pneumocystis pneumonia when T-cell dysfunction is significant. Mechanism/AE: as in #2; alternatives if sulfa allergy. Frontiers

20. Vaccinations (inactivated) — Not a drug “treatment,” but critical care*: give inactivated vaccines; avoid live vaccines if significant T-cell dysfunction unless an immunologist advises otherwise. Goal: reduce preventable infections; responses may be partial. Frontiers

---

Dietary molecular supplements

Evidence in TPPII is indirect (from immune-nutrition research and PID care). Avoid mega-doses. Check interactions and lab levels.

1. Vitamin D — daily maintenance (often 600–2,000 IU, individualized) to correct deficiency and support innate immune signals/antimicrobial peptides; benefit for respiratory infections is modest/variable across trials. Nature+1

2. Zinc — short courses (e.g., 10–20 mg elemental/day when deficient) support barrier integrity and lymphocyte function; excess impairs copper status—monitor. PMC+1

3. Vitamin C — dietary emphasis or modest supplementation supports neutrophil function and antioxidant defenses; high doses can cause GI upset or stones in predisposed people. PMC

4. Selenium (in deficiency) — cofactor for antioxidant enzymes aiding redox balance during infection; dosing should be conservative due to narrow safety margins. PMC

5. Omega-3 fatty acids — may temper excessive inflammation while maintaining host defense; use food-first or standard capsules; watch anticoagulant use. PMC

6. B-vitamins (B6, B12, folate) when low — support DNA synthesis and lymphocyte proliferation; replace after measuring levels to avoid masking other issues. PMC

7. Iron (only if iron-deficient) — corrects anemia to improve tissue oxygenation; avoid empiric iron in active infection without clinician oversight. PMC

8. Vitamin A (avoid excess) — supports mucosal barriers and antibody responses; toxicity risks mean diet-first or supervised dosing only. Frontiers

9. Probiotics (food-based preferred; supplement only if cleared) — potential gut-immune benefits in general populations, but rare bloodstream infections have occurred in immunocompromised hosts—specialist advice is essential. PMC+1

10. Multinutrient formula (low-dose, balanced) — when intake is poor, a standard multivitamin/mineral can cover gaps without mega-doses; targeted repletion remains best. PMC

---

Immunity-support/Regenerative/Stem-cell–related” drugs

1. IVIG/SCIG (replacement) — boosts missing antibodies and modulates over-active immunity; individualized dosing with infection logs and IgG troughs. Frontiers

2. G-CSF (filgrastim) — mobilizes neutrophils in neutropenia or during severe infections; not a cure but reduces immediate risk. Frontiers

3. GM-CSF (sargramostim) — can be considered to stimulate broader myeloid recovery in select scenarios; monitor for fever and leukocytosis. Frontiers

4. Interferon-γ — immunostimulant primarily for chronic granulomatous disease; sometimes considered off-label to enhance macrophage killing; PID specialists decide. Frontiers

5. Plerixafor (with G-CSF) for stem-cell mobilization — facilitates collection before HSCT; mechanism blocks CXCR4/SDF-1 axis to release stem cells. Frontiers

6. Sirolimus — not a “booster,” but by tuning mTOR, it can rebalance dysregulated immune metabolism in some immune-dysregulation PIDs; used as a targeted immunomodulator. PMC

---

Procedures/Surgeries

1. Hematopoietic stem-cell transplantation (HSCT) — replaces the defective immune system with donor stem cells; considered in severe, refractory immune-dysregulation PIDs or life-threatening courses; benefits must be weighed against transplant risks (GVHD, infections). Frontiers

2. Splenectomy — occasionally used for resistant Evans syndrome to reduce red-cell/platelet destruction; variable benefit and higher lifelong infection risk (needs vaccines/antibiotic plans). Medscape

3. Central venous access device (port) — facilitates repeated infusions (IVIG, antibiotics); it is a supportive procedure that improves treatment delivery but carries line-infection risk. Frontiers

4. Feeding tube (PEG) in severe failure to thrive — if oral intake is unsafe/insufficient, a tube can secure nutrition, which is fundamental to immune repair. Frontiers

5. Diagnostic biopsies (targeted) — bone marrow or lymph node biopsy when needed to clarify cytopenias or rule out other causes; guides safe, precise therapy. Frontiers

---

Prevention tips (daily life)

• Keep a written infection-action plan and go early for assessment with fever, fast breathing, or unusual fatigue. Frontiers

• Vaccinate household members and follow clinician advice on inactivated vaccines for the patient. Frontiers

• Maintain hand hygiene, surface disinfection, and masking in high-risk seasons or crowded indoor settings. Frontiers

• Food safety: fully cook meats/eggs; avoid unpasteurized dairy. Frontiers

• Dental/skin care routines to protect barriers. Frontiers

• Adequate sleep, movement, and nutrition; correct measured deficiencies (e.g., vitamin D, zinc) with clinician guidance. PMC

• Avoid live vaccines unless an immunologist deems them safe for your immune status. Frontiers

• Travel planning: medicines on hand, medical letter, and insurance for urgent care. Frontiers

• Pet and garden hygiene to reduce exposure to scratches, bites, and soil fungi. Frontiers

• Regular specialist follow-up (immunology/hematology), with labs to tune IVIG, drug levels, and side-effect monitoring. Frontiers

---

When to see a doctor

Seek urgent care for high fever, fast or difficult breathing, severe dehydration, unusual sleepiness/confusion, chest pain, new bleeding/bruising, yellowing of eyes, or dark urine (possible hemolysis). Arrange prompt clinic follow-up for recurrent ear/sinus/chest infections, persistent diarrhea/weight loss, mouth ulcers, or new neurologic concerns. In TPPII-related disease and Evans syndrome, early treatment prevents complications. Frontiers+1

---

What to eat and what to avoid

• Eat: balanced meals with lean protein, legumes, whole grains, colorful vegetables/fruits for vitamins and antioxidants—food-first supports immunity. PMC

• Eat: sources of vitamin D (oily fish, eggs) and zinc (meat, beans, nuts); consider clinician-guided supplements if objectively low. PMC

• Eat: fermented foods if cleared (yogurt, kefir) rather than high-dose probiotic pills. PMC

• Eat: adequate fluids; dehydration impairs mucus clearance. Frontiers

• Avoid: raw meats, raw eggs, unpasteurized dairy/juices, and unwashed produce to cut infection risk. Frontiers

• Avoid: mega-dose supplements unless prescribed—more is not better and can be harmful (e.g., vitamin A, zinc). PMC

• Avoid: alcohol excess, which disrupts immunity and sleep. PMC

• Avoid: high-sugar ultra-processed snacks as staples—focus on nutrient density. PMC

• Avoid: probiotic capsules without medical clearance (rare bloodstream infections reported in immunocompromised hosts). ScienceDirect

• Avoid: herbal products that may thin blood or interact with immunosuppressants unless your clinician reviews them. Frontiers

---

Frequently asked question

1. Is TPPII-related immunodeficiency curable?
   No single approved cure exists; HSCT may be considered in severe, refractory cases. Otherwise, care combines IVIG, infection prevention, and targeted control of autoimmunity. Frontiers

2. Why is Evans syndrome common here?
   TPPII defects disturb immune tolerance and metabolism, predisposing to autoimmune cytopenias like Evans syndrome. PMC+1

3. Are live vaccines safe?
   Usually avoided with significant T-cell dysfunction; your immunologist will advise case by case. Frontiers

4. Will IVIG fix the autoimmunity?
   IVIG mainly prevents infections and sometimes helps modulate autoimmunity, but many patients still need steroid-sparing agents (e.g., rituximab, sirolimus). PMC

5. Does rituximab work for Evans syndrome?
   Often effective as second-line therapy; dosing is typically 375 mg/m² weekly × 4. Monitor for prolonged low immunoglobulins and infections. haematologica.org+1

6. Could mTOR inhibitors help?
   By dialing down mTOR, drugs like sirolimus can rebalance immune-cell metabolism in some immune-dysregulation states; they require level monitoring. PMC

7. Are probiotics safe?
   Food sources may be fine, but supplement capsules carry rare infection risks in immunocompromised patients—use only with specialist guidance. ScienceDirect

8. Which vitamins help most?
   Correct documented deficiencies—especially vitamin D and zinc—rather than taking mega-doses. Evidence for preventing infections is mixed to modest overall. PMC+1

9. What triggers flares?
   Infections, missed medicines, and stress/sleep loss can precipitate cytopenias or infections; prevention plans help. Frontiers

10. Can children attend school?
    Yes—with plans for infection control, quick access to care, and individualized education supports if neurodevelopmental needs exist. orpha.net

11. Will my child outgrow it?
    This is genetic, so the tendency persists, but careful management can reduce complications and improve quality of life. orpha.net

12. Is genetic testing useful for relatives?
    Yes—autosomal recessive inheritance means parents are usually carriers; testing informs future family planning. NCBI

13. Are there new treatments coming?
    Research continues into immune metabolism and targeted immunomodulators; because the disease is ultra-rare, advances often generalize from related PIDs. ScienceDirect

14. Does HSCT always work?
    HSCT can be curative for immune defects but carries serious risks; outcomes vary and must be weighed carefully by a transplant-experienced PID team. Frontiers

15. Where can I read more?
    See the original reports and summaries: Cell (2014) first described human TPP2 deficiency; Blood (2015) linked it with Evans syndrome; Orphanet provides an accessible disease summary. ScienceDirect+2PMC+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 29, 2025.

PDF Documents For This Disease Condition References